Abstract:Endoplasmic reticulum stress (ERS) is usually involved in tumor development and progression, and anticancer agents have recently been recognized to induce ERS. Cucurbitacin-I showed a potent anticancer action by inducing apoptosis through the inhibition of signal transducer and activator of transcription 3 pathway and triggering autophagic cell death. It is not known whether ERS mediates the cancer cell death induced by cucurbitacin-I. Here, we investigated the role of ERS in cucurbitacin-I-treated SKOV3 ovarian cancer cells and PANC-1 pancreatic cancer cells. We confirmed that cucurbitacin-I caused cell death and stirred excessive ERS levels by activating inositol requiring enzyme 1 (IRE1) and protein kinase R-like endoplasmic reticulum kinase (PERK), as well as PERK downstream factors, includingIRE1 and C/EBP homologous protein, but not activating transcription factor 6 (ATF6) pathway, which was in parallel with the increased Bax and caspase-12-dependent ERS-associated apoptosis, autophagy and autophagy flux levels and caspase-independent nonapoptotic cell death. Furthermore, 4-phenylbutyrate, an ERS inhibitor, suppressed cucurbitacin-I-induced apoptosis, autophagy, autophagy flux, and autophagic cell death. Simultaneously, there are positive correlations among ERS and cucurbitacin-I-induced reactive oxygen speciesand Ca (2+). Our results suggested that cucurbitacin-I-induced cancer cell death through the excessive ERS and CHOP-Bax and caspase-12-dependent ERS-associated apoptosis, as well as ERS-dependent autophagy, autophagy flux, and caspase-independent nonapoptotic cell death. These novel signaling insights may be useful for developing new, effective anticancer strategies in oncotherapy.

Cucurbitacin E induces autophagy in HeLa cells by inhibiting mTORC1 activity

Cucurbitacin E Induces Autophagy Via Downregulating Mtorc1 Signaling and Upregulating AMPK Activity.

Cucurbitacin E Induces Autophagy-Involved Apoptosis in Intestinal Epithelial Cells

Knockdown of Autophagy-Related Gene LC3 Enhances the Sensitivity of HepG2 Cells to Epirubicin

Growth inhibitory effect of Cucurbitacin E on breast cancer cells.

Inhibitory Effect of Cucurbitacin E on the Proliferation of Breast Cancer Cells and Its Mechanism

Cucurbitacin I Induces Cancer Cell Death Through the Endoplasmic Reticulum Stress Pathway.

Cucurbitacin B induces cell cycle arrest, apoptosis and autophagy associated with G actin reduction and persistent activation of cofilin in Jurkat cells.

Cucurbitacin-I Induces Hypertrophy in H9c2 Cardiomyoblasts Through Activation of Autophagy Via MEK/ERK1/2 Signaling Pathway

Cucurbitacin B inhibits growth and induces apoptosis through the JAK2/STAT3 and MAPK pathways in SH‑SY5Y human neuroblastoma cells.

Cucurbitacin-I induces hypertrophy in H9c2 cardiomyoblasts through activation of autophagy via MEK/ERK1/2 signaling pathway.

In vitro antitumor effect of cucurbitacin E on human lung cancer cell line and its molecular mechanism

MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin.

Cucurbitacin B Inhibits Proliferation, Induces G2/M Cycle Arrest and Autophagy Without Affecting Apoptosis but Enhances MTT Reduction in PC12 Cells

Cucurbitacin I exerts its anticancer effects by inducing cell cycle arrest via the KAT2a-ube2C/E2F1 pathway and inhibiting HepG2-induced macrophage M2 polarization

Cucurbitacin E Inhibits Huh7 Hepatoma Carcinoma Cell Proliferation and Metastasis via Suppressing MAPKs and JAK/STAT3 Pathways

[Inhibitory effect of cucurbitacin E on the proliferation of ovarian cancer cells and its mechanism].

Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells

Inhibitory effect and mechanism of cucurbitacin E on the proliferation of ovarian cancer cells

Antitumor Mechanism of Hydroxycamptothecin on Cervical Cancer by Inducing Cell Autophagy

Cucurbitacin E Exerts Anti-Proliferative Activity via Promoting p62-Dependent Apoptosis in Human Non-Small-Cell Lung Cancer A549 Cells